BOSTON SCIENTIFIC CORP
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Boston Scientific Cuts Outlook Amid Weak Demand for Watchman Heart Device
Boston Scientific (BSX) lowered its full-year guidance below Wall Street's estimates on Wednesday, c
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made the biggest moves today.
Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock?
BSX faces Q2 results with growth expected in key businesses, but lowered full-year guidance, cost pressures and weak stock performance cloud the outlook.
DATAMYTE Achieves ISO/IEC 27001:2022 Certification for Digital Clipboard, Its No-Code Manufacturing Workflow Platform
ASI DATAMYTE, Inc. ("DATAMYTE"), a leading provider of production and quality management solutions serving over 1000 manufacturers including Ford, Boston Scientific, Northrop Grumman, CS Wind, Stellantis, Boeing, Tesla, Gillette, Borg Warner, Cabinetworks Group, Foxconn, Pepsico, GM, and more, announced today that it has achieved ISO/IEC 27001:2022 certification for the information security management system (ISMS) supporting Digital Clipboard, its cloud-based, no-code manufacturing workflow pla
Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $62
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $64 to $62.
Why Did SPCX, IBM, BSX Drop To 52-Week Lows Today?
SpaceX, IBM and Boston Scientific fell to 52-week lows on Wednesday as Wall Street concerns and profit-taking sent the stocks lower.
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?
Shareholders of Boston Scientific would probably like to forget the past six months even happened. The stock dropped 52.5% and now trades at $42.79. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Mizuho Maintains Outperform on Boston Scientific, Lowers Price Target to $70
Mizuho analyst Anthony Petrone maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $90 to $70.
Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside
With an upside potential of 62.55%, Boston Scientific Corporation (NYSE:BSX) is among the 12 Strong Buy Stocks with High Upside According to Analysts. On July 8, Needham analyst Mike Matson lowered the firm’s price target on Boston Scientific Corporation (NYSE:BSX) to $57 from $77 while maintaining a Buy rating on the shares. The adjustment followed management commentary […]
Are Boston Scientific’s (BSX) Sterile-Packaging Recalls Reframing the Narrative on Quality and Regulatory Risk?
Boston Scientific recently initiated several voluntary Class II recalls of its CRE and CRE Pro Wireguided endoscopy devices worldwide due to potential sterile breaches in packaging, affecting tens of thousands of units across multiple size ranges. The recalls underscore the operational and regulatory risks inherent in Boston Scientific’s expanding minimally invasive device portfolio, especially as it integrates recent acquisitions and scales global distribution. We’ll now examine how these...
Congressional Trades in $BSX
Insider Trades (Form 4)
O'Connor Padraig Andrew
Butcher Arthur C
Key People
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
OConnor Padraig Andrew
EVP, Global Operations
Political Giving
$166,500 given to 40 candidates across 89 disclosed contributions (FEC Schedule A).
Adrian Smith
Katherine M. Clark
Bradley S. Schneider
Carol Devine Miller
Gus M. Bilirakis
Terri A. Sewell
Lori Trahan
Markwayne Mullin
John Cornyn
Suzan K. DelBene
Bill Cassidy
Blake Moore
Darin McKay LaHood
Kim Schrier
Lisa McClain
Ruben Gallego
Kevin Hern
James E Hon Banks
John Curtis
Linda T. Sanchez
+ 20 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro